Cargando…

Effects of stem cell therapy on dilated cardiomyopathy

OBJECTIVES: To perform a meta-analysis of clinical trials and investigate the effect of stem cell therapy on dilated cardiomyopathy. METHODS: A systematic literature search was carried out between May 2012 and July 2013 in PubMed, Medline, Cochrane Library, and Excerpta Medica Database (EMBASE). The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiao, Rong, Liu, Yuan, Yang, Wen-Jian, Zhu, Xiao-Yan, Li, Jin, Tang, Qi-Zhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Saudi Medical Journal 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4362159/ https://www.ncbi.nlm.nih.gov/pubmed/25491210

Ejemplares similares

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy: a systematic appraisal and meta-analysis
por: Rong, Shu-Ling, et al.
Publicado: (2019)

Effect of β-Blocker Therapy on the Level of Soluble ST2 Protein in Pediatric Dilated Cardiomyopathy
por: Jiao, Meng, et al.
Publicado: (2022)

Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy
por: Jiao, Meng, et al.
Publicado: (2018)

Effect of cardiac resynchronisation therapy in dilated cardiomyopathy
por: Bouwmeester, S., et al.
Publicado: (2021)

Circular RNA Expression for Dilated Cardiomyopathy in Hearts and Pluripotent Stem Cell–Derived Cardiomyocytes
por: Zhang, Yiyu, et al.
Publicado: (2021)

A predictive model for dilated cardiomyopathy with pulmonary hypertension
por: Liang, Jiahua, et al.
Publicado: (2021)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Drug Therapy in Dilated Cardiomyopathy and Myocarditis
por: Barron, Hal
Publicado: (1989)

Prognostic value of free triiodothyronine in patients with dilated cardiomyopathy
por: Zhao, Hong-Yan, et al.
Publicado: (2020)

HLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy
por: Jin, B., et al.
Publicado: (2016)

Apoptosis in Dilated Cardiomyopathy
por: Hong, Bum Kee, et al.
Publicado: (2000)

Beneficial effects of intramyocardial mesenchymal stem cells and VEGF(165) plasmid injection in rats with furazolidone induced dilated cardiomyopathy
por: Yu, Qin, et al.
Publicado: (2015)

The Potential of Metabolism-Related Gene OGDHL as a Biomarker for Myocardial Remodeling in Dilated Cardiomyopathy
por: Tang, Yaohan, et al.
Publicado: (2022)

Monocyte Chemotactic Protein-1 Promotes the Myocardial Homing of Mesenchymal Stem Cells in Dilated Cardiomyopathy
por: Guo, Jing, et al.
Publicado: (2013)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Cardiomyopathy, familial dilated
por: Taylor, Matthew RG, et al.
Publicado: (2006)

Dilated cardiomyopathy in childhood
por: Franklin, OM, et al.
Publicado: (2000)

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Nonspecific intraventricular conduction delay predicts the prognosis of dilated cardiomyopathy
por: Yuan, Yong, et al.
Publicado: (2023)

A nomogram predicting atrial fibrillation in patients with dilated cardiomyopathy
por: Mao, Yangming, et al.
Publicado: (2022)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Evaluation of Drug-Related Receptors in Children With Dilated Cardiomyopathy
por: Guo, Qing, et al.
Publicado: (2019)

The Molecular Role of Immune Cells in Dilated Cardiomyopathy
por: Wang, Enping, et al.
Publicado: (2023)

Dilated cardiomyopathy and aldosteronoma: a causal link?
por: Zhang, Jiyu, et al.
Publicado: (2019)

Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
por: Ikeda, Uichi, et al.
Publicado: (2008)

New Insights Into the Therapy for Lamin-Associated Dilated Cardiomyopathy
por: Zhang, Hao, et al.
Publicado: (2022)

Intracoronary allogeneic cardiosphere‐derived stem cells are safe for use in dogs with dilated cardiomyopathy
por: Hensley, Michael Taylor, et al.
Publicado: (2017)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Cardiac Magnetic Resonance for evaluating early outcomes of stem cell therapy in non-ischemic dilated cardiomyopathy
por: Gulati, Gurpreet S, et al.
Publicado: (2011)

The role of Asprosin in patients with dilated cardiomyopathy
por: Wen, Ming-Shien, et al.
Publicado: (2020)

Genetics of BAG3: A Paradigm for Developing Precision Therapies for Dilated Cardiomyopathies
por: Qu, Hui‐Qi, et al.
Publicado: (2022)

Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy
por: Xu, Man, et al.
Publicado: (2022)

Oral Chinese Herbal Medicine for Treatment of Dilated Cardiomyopathy: A Systematic Review and Meta-Analysis
por: Zhu, Yu-Shuo, et al.
Publicado: (2016)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

YAP activation promotes the transdifferentiation of cardiac fibroblasts to myofibroblasts in matrix remodeling of dilated cardiomyopathy
por: Jin, Bo, et al.
Publicado: (2018)

Dilated cardiomyopathy: antifibrotic effect of IGF1
Publicado: (2012)

Analysis of the role of glucose metabolism-related genes in dilated cardiomyopathy based on bioinformatics
por: Chen, Keping, et al.
Publicado: (2023)

LMNA-related dilated cardiomyopathy
por: Vaikhanskaya, Tatiyana, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sf1ts3ghanbiccvoe3mnbcpats